About Red Herring
is a global media company uniting the world's best high-technology innovators, venture investors, and business decision-makers in a variety of forums: a leading innovation magazine, an online daily technology news service technology newsletters, and major events for technology leaders around the globe.
provides an insider's view of the global innovation ecosystem, featuring unparalleled insights on the emerging technologies driving the economy.
BONESUPPORT is an emerging leader of injectable bone substitutes for orthopedic trauma focusing on bone infection, instrument augmentation related to orthopedic surgery and spinal applications.
CERAMENT™ is an injectable, synthetic bone substitute that mimics the properties of cancellous bone, allows for controlled resorption to support future bone ingrowth and is injectable under local anesthesia for minimally invasive surgery. CERAMENT's unique biologic properties deliver a consistent, pre-packed and ready-to-use formulation to facilitate optimal delivery.
CERAMENT™ is a fully developed product platform that is commercially available in the U.S. and
and is revolutionizing the treatment of fragility and other fractures caused by disease and trauma. Scientific research of CERAMENT spans more than eleven years and over forty-five pre-clinical, clinical and animal studies have been conducted. More than 4,000 patients have been treated with CERAMENT. The company was founded in 1999 and is based in
with subsidiary locations in the US and
. To learn more about BONESUPPORT please visit
Offer NonhoffChief Financial Officer
Phone +46 46 286 53 60